Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Acquisitions: 2022-2025

  • Maravai Lifesciences Holdings' Acquisitions was N/A to $362,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $88.6 million, marking a year-over-year change of. This contributed to the annual value of $69.6 million for FY2023, which is 70.87% down from last year.
  • As of Q2 2025, Maravai Lifesciences Holdings' Acquisitions stood at $362,000, which was down 98.06% from $18.6 million recorded in Q1 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Acquisitions ranged from a high of $238.8 million in Q1 2022 and a low of -$109,000 during Q2 2023.
  • In the last 2 years, Maravai Lifesciences Holdings' Acquisitions had a median value of $9.5 million in 2025 and averaged $22.2 million.
  • Data for Maravai Lifesciences Holdings' Acquisitions shows a maximum YoY crashed of 70.80% (in 2023) over the last 5 years.
  • Over the past 3 years, Maravai Lifesciences Holdings' Acquisitions (Quarterly) stood at $133,000 in 2022, then slumped by 70.80% to -$109,000 in 2023, then reached $362,000 in 2025.
  • Its Acquisitions stands at $362,000 for Q2 2025, versus $18.6 million for Q1 2025 and -$109,000 for Q2 2023.